Sign up
Pharma Capital
Market: LSE
52-week High/Low: 421.50p / 246.50p
Sector: Health Care, Equipment & Services
Market Cap: 2,700.80M

The world leader in addiction treatment with 20 years of experience and a unique, patient-focused approach.We didn’t become the world leader in addiction treatment overnight.  Our endeavor started small, with one singular focus – to intimately understand the journey of individuals suffering with addiction. People with addiction are often stereotyped and discounted, creating an environment where many are under-diagnosed, undertreated and under-supported. They’re often unaware of their treatment options, have limited access to treatment, or simply don’t seek it out because they’re afraid of being stigmatized.


Interactive graph

col 3
col 4
col 5
col 6

Indivior Timeline

View All

Market Reports Including INDV


Executive video interviews


© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.